Morphgesic Sr (Morphine Sulfate)

Morphine Sulfate, the active ingredient in Morphgesic Sr, is an opioid analgesic presented as an oral formulation for oral use. It is employed to treat moderate to severe pain in adult patients when other analgesics are insufficient. The drug acts centrally on the nervous system to provide effective pain relief and sedation, and is classified as a Schedule II controlled substance in the EU.

GNH USA supplies Morphgesic Sr as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and regulatory requirements.

Morphine Sulfate is used in the management of pain conditions that involve the central opioid pathway. - Moderate to severe acute pain: provides rapid analgesia to reduce discomfort. - Postoperative pain: controls pain following surgical procedures. - Cancer‑related pain: alleviates chronic malignant pain in adult patients.

Morphine Sulfate may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Nausea: sensation of queasiness. - Drowsiness: mild sedation. - Dry mouth: decreased salivation.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing that can be life‑threatening. - Severe hypotension: marked drop in blood pressure. - Dependence or addiction: potential for misuse with prolonged use.

When prescribing Morphine Sulfate, clinicians should observe several safety considerations to minimize risk. - Assess pain severity: confirm that opioid therapy is appropriate. - Evaluate respiratory function: monitor for depression, especially in opioid‑naïve patients. - Review concomitant CNS depressants: avoid or adjust doses when combined with benzodiazepines or alcohol. - Use lowest effective dose: titrate to achieve analgesia while limiting side effects. - Pregnancy and lactation: consider unknown safety; weigh benefits against potential risks. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and light.

Morphine Sulfate can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Other opioids: additive respiratory depression. - CNS depressants (e.g., benzodiazepines, barbiturates): increased sedation and respiratory risk. - MAO inhibitors: risk of severe hypotension and serotonin syndrome.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): may increase morphine levels. - CYP3A4 inducers (e.g., rifampin): may reduce efficacy. - Anticholinergics: may worsen constipation. - Diuretics: may enhance hypotensive effect.